Tabituximab barzuxetan (exclude Y90), CAS 1612758-88-9

Product Description: Tabituximab barzuxetan (exclude Y90) is a radioimmunoconjugate composed of a humanized monoclonal antibody targeting FZD-10 (OTSA-101). Tabituximab barzuxetan shows antineoplastic activity. Tabituximab barzuxetan can be used for synovial sarcoma research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Anne-Laure Giraudet , et al. A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients. BMC Cancer. 2018 Jun 8;18(1):646.

CAS Number: 1612758-88-9

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Wnt

• SKU: MEXHY-P99581-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99581-5
• Green Labware: No
• Package Unit: 5mg
• Quantity Unit: STK